Search - tctmd.com

Displaying 81 - 100 of 535

Sort: Relevancy | Date

Presentation NY Valves 2024

Not So Fast! Surgical Repair and Replacement Are Still the Gold Standard for AR Therapy!

Presenter: Hiroo Takayama

June 07, 2024

Presentation NY Valves 2024

TAVR Therapy for Chronic AR: Focus on Dedicated TAVR Devices

Presenter: Torsten P. Vahl

June 07, 2024

Presentation NY Valves 2024

How Can We Improve the Diagnosis of Significant AR? The Case for Multi-Modality Imaging!

Presenter: Omar K. Khalique

June 07, 2024

Presentation NY Valves 2024

How Serious Is the Underdiagnosis and Undertreatment Problem With Chronic AR?

Presenter: Saif Anwaruddin

June 07, 2024

Presentation NY Valves 2024

KEYNOTE LECTURE: Chronic Aortic Regurgitation – Diagnostic Challenges, Current Treatment Guidelines, and Future Directions

Presenter: Robert O. Bonow

June 07, 2024

Presentation NY Valves 2024

Meta-Analysis of Dedicated Versus Off-Label TAVR for Native Aortic Regurgitation

Presenter: Sahar Samimi

June 07, 2024

Presentation NY Valves 2024

Hemodynamic Performance of the JenaValve Trilogy™ System in Patients With Severe Aortic Valve Stenosis: Insights From ALIGN-AS and Commercial Experience

Presenter: Matti Adam

June 07, 2024

Presentation NY Valves 2024

The Effect of Baseline Left Ventricular Ejection Fraction on Reverse Remodeling After Jenavalve Trilogy Transcatheter Aortic Valve Replacement in Patients With Pure Aortic Regurgitation: An Analysis From the ALIGN-AR Trial

Presenter: Lauren Sharan Ranard

June 07, 2024

Presentation NY Valves 2024

ALIGN-AR Continued Access Study Shows Positive Safety Outcomes for the First Dedicated Transcatheter Aortic Valve for Aortic Regurgitation

Presenter: Raj Makkar

June 07, 2024

Presentation NY Valves 2024

Transcatheter Aortic Valve Implantation for Pure Aortic Valve Regurgitation? Insights From the France-TAVI Nationwide French Registry: The PAVR Study

Presenter: Robin Le Ruz

June 07, 2024

Presentation NY Valves 2024

Medical, Surgical, and Transcatheter Treatment of Chronic Aortic Regurgitation

Presenter: Santiago Garcia

June 06, 2024

Presentation NY Valves 2024

Role of Exercise Testing in Assessment of AR

Presenter: Robert O. Bonow

June 06, 2024

Presentation NY Valves 2024

Case Presentation: Imaging in Asymptomatic AR – Diagnosis, Risk Assessment, and Follow-up

Presenter: Scott M. Chadderdon

June 06, 2024

Presentation NY Valves 2024

Ultima Ratio: Emergency TAVR for Acute Iatrogenic Aortic Regurgitation During Endovascular Aortic Stenting

Presenter: Jonathan Michel

June 06, 2024

Presentation NY Valves 2024

First TAVR-in-TAVR for a Dedicated Self-Expandable Device for Pure Aortic Regurgitation

Presenter: Jonathan Curio

June 06, 2024

Presentation NY Valves 2024

Successful Self-Expanding TAVR in Severe Native AR With a Large Annulus (700+) Early Post Cardiac Surgery

Presenter: UTTAM SINGH

June 06, 2024

Presentation NY Valves 2024

JenaValve Following Previous Ross Procedure

Presenter: Daniel Zumerkorn Hassan

June 06, 2024

Presentation NY Valves 2024

Transcatheter Heart Valve for Treatment of Pure Native AR With Minimal AV Calcium, Large Annulus and Large Aorta

Presenter: Hasan Jilaihawi

June 06, 2024

Presentation NY Valves 2024

Real Dilemma: Precious Pregnancy With Severe Aortic Stenosis, Moderate Severe Aortic Regurgitation

Presenter: Rajneesh Kapoor

June 06, 2024

Presentation NY Valves 2024

Transfemoral TAVI With Dedicated Device for Severe Aortic Regurgitation in Patient With Left Ventricular Assist Device With Aortic Cusp Thrombus

Presenter: Simon Lam

June 06, 2024

Advertisement

Not So Fast! Surgical Repair and Replacement Are Still the Gold Standard for AR Therapy!

TAVR Therapy for Chronic AR: Focus on Dedicated TAVR Devices

How Can We Improve the Diagnosis of Significant AR? The Case for Multi-Modality Imaging!

How Serious Is the Underdiagnosis and Undertreatment Problem With Chronic AR?

KEYNOTE LECTURE: Chronic Aortic Regurgitation – Diagnostic Challenges, Current Treatment Guidelines, and Future Directions

Meta-Analysis of Dedicated Versus Off-Label TAVR for Native Aortic Regurgitation

Hemodynamic Performance of the JenaValve Trilogy™ System in Patients With Severe Aortic Valve Stenosis: Insights From ALIGN-AS and Commercial Experience

The Effect of Baseline Left Ventricular Ejection Fraction on Reverse Remodeling After Jenavalve Trilogy Transcatheter Aortic Valve Replacement in Patients With Pure Aortic Regurgitation: An Analysis From the ALIGN-AR Trial

ALIGN-AR Continued Access Study Shows Positive Safety Outcomes for the First Dedicated Transcatheter Aortic Valve for Aortic Regurgitation

Transcatheter Aortic Valve Implantation for Pure Aortic Valve Regurgitation? Insights From the France-TAVI Nationwide French Registry: The PAVR Study

Medical, Surgical, and Transcatheter Treatment of Chronic Aortic Regurgitation

Role of Exercise Testing in Assessment of AR

Case Presentation: Imaging in Asymptomatic AR – Diagnosis, Risk Assessment, and Follow-up

Ultima Ratio: Emergency TAVR for Acute Iatrogenic Aortic Regurgitation During Endovascular Aortic Stenting

First TAVR-in-TAVR for a Dedicated Self-Expandable Device for Pure Aortic Regurgitation

Successful Self-Expanding TAVR in Severe Native AR With a Large Annulus (700+) Early Post Cardiac Surgery

JenaValve Following Previous Ross Procedure

Transcatheter Heart Valve for Treatment of Pure Native AR With Minimal AV Calcium, Large Annulus and Large Aorta

Real Dilemma: Precious Pregnancy With Severe Aortic Stenosis, Moderate Severe Aortic Regurgitation

Transfemoral TAVI With Dedicated Device for Severe Aortic Regurgitation in Patient With Left Ventricular Assist Device With Aortic Cusp Thrombus

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content